42
Views
119
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Akt Phosphorylation of Serine 21 on Pak1 Modulates Nck Binding and Cell Migration

, , , , &
Pages 8058-8069 | Received 31 Mar 2003, Accepted 13 Aug 2003, Published online: 27 Mar 2023
 

Abstract

The p21-activated protein kinases (Paks) regulate cellular proliferation, differentiation, transformation, and survival through multiple downstream signals. Paks are activated directly by the small GTPases Rac and Cdc42 and several protein kinases including Akt and PDK-1. We found that Akt phosphorylated and modestly activated Pak1 in vitro. The major site phosphorylated by Akt on Pak1 mapped to serine 21, a site originally shown to be weakly autophosphorylated on Pak1 when Cdc42 or Rac activates it. A peptide derived from the region surrounding serine 21 was a substrate for Akt but not Pak1 in vitro, and Akt stimulated serine 21 phosphorylation on the full-length Pak1 much better than Rac did. The adaptor protein Nck binds Pak near serine 21, and its association is regulated by phosphorylation of this site. We found that either treatment of Pak1 in vitro with Akt or coexpression of constitutively active Akt with Pak1 reduced Nck binding to Pak1. In HeLa cells, green fluorescent protein-tagged Pak1 was concentrated at focal adhesions and was released when Akt was cotransfected. A peptide containing the Nck binding site of Pak1 fused to a portion of human immunodeficiency virus Tat to allow it to enter cells was used to test the functional importance of Nck/Pak binding in Akt-stimulated cell migration. This Tat-Nck peptide reduced Akt-stimulated cell migration. Together, these data suggest that Akt modulates the association of Pak with Nck to regulate cell migration.

ACKNOWLEDGMENTS

We thank Alex Toker for the baculovirus Akt and PDK-1 expression systems and Jonathan Chernoff for WT and KD baculovirus Pak constructs. We also thank Amita Sehgal and members of the lab for helpful discussions and for comments on the manuscript.

This work was supported by grants from the NIH to G.B. (GM44428 and GM39434) and to J.F. (GM48241), and by grants to J.F. from the DOD neurofibromatosis program (DAMD17-01-1-0719) and the American Cancer Society (RPG-99-102-01-TBE). C.C.K. was supported by the Heme and Blood Proteins training grant. B.H.F. was supported by NIH training grant CA09677.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.